ArticleJournal of bone metabolism2025

Emerging Role of Myostatin Inhibitors in the Management of Glucagon-Like Peptide-1-Associated Sarcopenia and Metabolic Disorders.

Jongmin Baik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.